EUCTR2014-003573-42-SE进行中（未招募）1 期
Antibody-mediated immune response after immunization with FSME-Immun(R) against Tick Borne Encephalitis(TBE) after hematopoietic autologous and allogeneic stem cell transplantation.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Age 18 or above
- •2.Informed consent
- •FOR ALLO SCT PTS: myeloablative or reduced conditioning, sibling donor or matched unrelated donor, diagnosis of acute or chronic leukemia, lymphoma, myelofibrosis
- •FOR AUTO SCT PTS: Pts with multiple myeloma, chronic lymphocytic leukemia, lymphoma or solid tumour with established indication
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 75
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •1. Relapse
- •2. Ongoing infection
- •3. Allergy to egg, hen protein or lathex
- •4. Previous TBE-disease
- •5. Pregnancy or wish to get pregnant
- •6. Recent(3 months) treatment with iv or sc immunoglobulin
- •FOR ALLOSCT PATIENTS: Patients transplanted with chord blood or from haploidentical donor
研究者
相似试验
招募中
不适用
Evaluation of antibody production after vaccination with COVID-19 in volunteer donorsJPRN-jRCT1071210129Kawasaki Tatsuhiko30
进行中（未招募）
4 期
eutralizing Immunogenicity Antibody After 2 Intradermal Doses Pre-Exposure Prophylaxis of Purified Vero Cell Rabies Vaccine (PVRV) to 12-24 month-old Children, concomitantly with Chimeric Live-Attenuated JE Vaccine (IMOJEV)To describe immune response and proportion of seroprotective level of JE at baseline prebooster vaccinationRabies,Rabies vaccination,Japanese encephalitis,Japanese encephalitis vaccinationTCTR20180531004Queen Saovabha Memorial Institute, The Thai Red Cross Society49
招募中
不适用
Immunological response after early extra and regular MMR immunization; 10 years follow-upNL-OMON56402RIVM80
尚未招募
不适用
Immunological response after early extra and regular MMR immunization; 6 years follow-upMeasles infection, paramyxovirusNL-OMON26839RIVM105
已完成
不适用
Immunological response after early extra and regular MMR immunization; 6 years follow-upNL-OMON48447RIVM90